Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07346846
PHASE1
A Study of BGM-2121 in Patients With Advanced Solid Tumors
Sponsor: BioGate Precision Medicine Corp.
View on ClinicalTrials.gov
Summary
This study is to explore the safety, tolerability, pharmacokinetics, and preliminary efficacy of BGM-2121 in adult patients with advanced solid tumors.
Official title: A Phase 1 First-in-human Study of BGM-2121 in Patients With Advanced Solid Tumors
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
35
Start Date
2026-02
Completion Date
2028-12
Last Updated
2026-03-02
Healthy Volunteers
No
Conditions
Interventions
DRUG
BGM-2121
BGM-2121 treatment
Locations (3)
National Cheng Kung University Hospital
Tainan, Taiwan
National Taiwan University Hospital
Taipei, Taiwan
Taipei Veterans General Hospital
Taipei, Taiwan